Teladoc Health, Inc.·4

Jun 3, 4:25 PM ET

DIVITA CHARLES III 4

4 · Teladoc Health, Inc. · Filed Jun 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Teladoc (TDOC) CEO Charles Divita Exercises Awards, Sells 19,132 Shares

What Happened
Teladoc CEO Charles Divita exercised/converted vested performance and restricted stock units into common shares on June 1, 2026, and sold 19,132 of those shares in an open-market transaction on June 2, 2026 for $7.63 each (total proceeds $145,920). The filing shows conversions of 1,966 shares and 42,276 shares (total 44,242 shares converted); after selling 19,132 shares to cover taxes, Divita’s net increase was 25,110 shares. The conversions were recorded at $0 exercise price (they were unit-to-share conversions, not a cash purchase).

Key Details

  • Transaction dates and prices:
    • 2026-06-01: Converted/ exercised 1,966 and 42,276 performance/restricted units into shares (derivative conversion; $0 cash exercise).
    • 2026-06-02: Sold 19,132 shares @ $7.63 = $145,920 (open-market sale).
  • Net change: +44,242 shares converted; -19,132 sold; net +25,110 shares retained.
  • Shares owned after transaction: not specified in the filing.
  • Notable footnotes:
    • F1/F2: PSUs and RSUs convert one-for-one into common stock.
    • F3: The 19,132 shares were sold to cover the tax withholding obligation related to vesting.
    • F4/F5: The PSUs/RSUs reflected vesting schedules (some vested March 1, 2026 with remainder vesting quarterly).
  • Filing timeliness: Filed June 3, 2026 for transactions on June 1–2, 2026 — appears timely (Form 4 is due within two business days).

Context
This was primarily a conversion of vested equity awards with a routine sale to satisfy tax withholding, not a cash purchase. For retail investors, conversions and withholding sales are common following vesting and do not necessarily signal a change in the insider’s view of the company.

Insider Transaction Report

Form 4
Period: 2026-06-01
DIVITA CHARLES III
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-06-01+1,966366,750 total
  • Exercise/Conversion

    Common Stock

    [F2]
    2026-06-01+42,276409,026 total
  • Sale

    Common Stock

    [F3]
    2026-06-02$7.63/sh19,132$145,920389,894 total
  • Exercise/Conversion

    Performance Stock Units

    [F1][F4]
    2026-06-011,96613,761 total
    Common Stock (1,966 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F2][F5]
    2026-06-0142,276295,939 total
    Common Stock (42,276 underlying)
Footnotes (5)
  • [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
  • [F4]On March 1, 2026, the reporting person earned 23,591 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F5]On March 1, 2025, the reporting person was granted 507,322 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact|2026-06-03

Documents

1 file
  • 4
    wk-form4_1780518304.xmlPrimary

    FORM 4